Dietary modifications may not benefit cancer patientsJuly 19, 2006One study, a meta-analysis of 59 trials, found little evidence that diet is associated with survival or prognosis. The other study suggests that neither use of garlic nor vitamin supplements delays the progression of precancerous gastric lesions to cancer. Numerous studies have linked dietary modifications and vitamins to cancer prevention and treatment. But researchers are worried that some dietary changes may not be harmless, a concern echoed by a European Union recommendation to tighten sales of supplements. Steven Thomas, M.D., Ph.D., of the University of Bristol in the United Kingdom, and colleagues used database searches to identify 59 trials that investigated the effects of a diverse range of nutritional interventions on patients with a previous diagnosis of cancer or precancerous lesions. Trial results were combined using meta-analysis. The authors suggest that the trials provide little evidence that specific interventions have any effect on disease-free survival, mortality, or recurrence. They say the impact of most nutritional interventions cannot be estimated reliably because of the limited number of trials, many of which are small or of low quality. The authors write, "The large personal expenditure on supplements and dietary modifications by patients with cancer demonstrates an urgent need to understand their effects on cancer outcomes. This vulnerable group of people need to be better informed as diet is one of the few areas of their lives where they may feel that they have some control." A second study of Chinese adults showed that garlic and vitamin supplements did not reduce the prevalence of precancerous lesions or gastric cancer, but treatment to kill Helicobacter pylori may limit the progression of these lesions to cancer and reduce their prevalence. In Linqu County, China, gastic cancer causes 42% of all cancer deaths, and H. pylori bacteria is present in 67% of adults. H. pylori causes gastric cancer. Wei-Cheng You, M.D., of the Beijing Institute for Cancer Research, Mitchell Gail, M.D., Ph.D., of the National Cancer Institute in Bethesda, Md., and colleagues tested 3,365 Chinese adults ages 35-64 in Linqu County. Beginning in 1995, the subjects were randomly assigned to receive various combinations of three interventions-one-time treatment with antibiotics for H. pylori; long-term vitamin E, C, and selenium supplements; or long-term garlic supplements-or a placebo. The researchers reassessed the patients in 1999 and 2003. The authors found that one-time use of the antibiotics amoxicillin and omeprazole to treat H. pylori infection reduced the severity and progression of precancerous gastric lesions. The data also suggested, but did not prove, that antibiotic treatment reduced gastric cancer incidence. Long-term vitamin and garlic supplementation had no effect on the incidence of gastric cancer or progression of precancerous lesions. The authors write, " H. pylori treatment reduces the prevalence of precancerous gastric lesions and may reduce gastric cancer incidence [...] Long-term vitamin or garlic supplementation had no beneficial effects." In an accompanying editorial examining both studies, John A. Baron, M.D., of Dartmouth Medical School in Lebanon, N.H., discusses reasons the two studies may have come to negative conclusions and suggests changes that could have been made to the study designs. He writes, "Together the two articles in this issue of the Journal well illustrate the contemporary status of chemoprevention: hard to summarize, many negative findings, but some nuggets of progress." Journal of the National Cancer Institute |
|||||||||||||||||||||
| Related Cancer Current Events and Cancer News Articles Scientists successfully reprogram blood cells Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome. Newly Discovered Fat Molecule: An Undersea Killer with an Upside A chemical culprit responsible for the rapid, mysterious death of phytoplankton in the North Atlantic Ocean has been found by collaborating scientists at Rutgers University and the Woods Hole Oceanographic Institution (WHOI). This same chemical may hold unexpected promise in cancer research. For young boys with cancer, testicular tissue banking may be option to preserve fertility For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility. CSHL study shows that some malignant tumors can be shut down after all Oncologists have had their hands tied because more than half of all human cancers have mutations that disable a protein called p53. Hundreds of genes distinguish patients likely to survive advanced melanoma Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. New imagining technique could lead to better antibiotics and cancer drugs A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. SNM applauds House action to build medical isotopes reactor in the US SNM applauds the U.S. House of Representatives for its passage of H.R. 3276-the American Medical Isotopes Production Act of 2009. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||